North America Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Neurological Centers)

North America Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Neurological Centers)

The North America cerebrospinal fluid management market is expected to reach US$ 1,060.40 million by 2028 from US$ 760.52 million in 2021; it is estimated to grow at a CAGR of 4.9% from 2021 to 2028. The growth of the market is attributed to the increasing incidence of cerebrospinal fluid (CSF) leaks and growing developments for CSF management products. However, the risk associated with CSF shunts hinders the market growth.

Brain and spinal injuries are the most common causes of cerebrospinal fluid (CSF) leak in adults, necessitating CSF management. According to the Journal of Neurosurgery, more than 69 million people globally are expected to suffer from traumatic brain injuries annually. Therefore, it is expected that brain and spinal injuries are among the major driving factors for CSF management.

Other leading factor for the CSF leak among adults and elders is high blood pressure, which is majorly caused due to shift in lifestyle and unhealthy habits. Similarly, the increasing number of older people leads to rising incidences of high blood, which ultimately leads to an increasing risk of idiopathic intracranial hypertension (IIH).

On the other hand, the incidences of hydrocephalus are growing significantly across the world. Also, the data published by the Hydrocephalus Association states that in the United States, 1 in every 770 babies develops hydrocephalus, and over 1 million people live with hydrocephalus in the country. Therefore, considering the aforementioned factors, the demand for CSF management market is likely to grow significantly in the coming future. Growing advancements in the field of medical devices have led to extraordinary developments and innovations. The growing demand for better treatments has resulted in various product developments, resulting in market growth. For instance, in January 2020, Biocept initiated the commercial launch of CSF assay and CNSide. CNSide assists in identifying and managing the treatment of metastatic cancers that involves the central nervous system. Furthermore, CNSide is designed for quantitative tumor cell capture and detection method, and these analyses are paired with assays to identify molecular treatment targets.

North America has been adversely affected by the COVID-19 pandemic. However, the situation varies from one country to another across the region. COVID-19 outbreak posed problems for health systems across the US in 2020. However, recent spikes in cases and hospitalizations suggest that pressure will become widespread in the coming months, with less resiliency across the country to support surges in care demand. To manage demand early in the pandemic, some clinicians relied on resources from other parts of the country, such as supplies, and postponed

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America cerebrospinal fluid management market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America cerebrospinal fluid management market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.